Cargando…

Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism

Among neurological adverse reactions in patients with schizophrenia treated with antipsychotics (APs), drug-induced parkinsonism (DIP) is the most common motility disorder caused by drugs affecting dopamine receptors. One of the causes of DIP is the disruption of neurotransmitter interactions that r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaiman, Elena E., Shnayder, Natalia A., Khasanova, Aiperi K., Strelnik, Anna I., Gayduk, Arseny J., Al-Zamil, Mustafa, Sapronova, Margarita R., Zhukova, Natalia G., Smirnova, Daria A., Nasyrova, Regina F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405702/ https://www.ncbi.nlm.nih.gov/pubmed/36009557 http://dx.doi.org/10.3390/biomedicines10082010

Ejemplares similares

Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
por: Nasyrova, Regina F., et al.
Publicado: (2023)

Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
por: Khasanova, Aiperi K., et al.
Publicado: (2022)

The Role of D-Serine and D-Aspartate in the Pathogenesis and Therapy of Treatment-Resistant Schizophrenia
por: Nasyrova, Regina F., et al.
Publicado: (2022)

Genetic Predictors of Antipsychotic Efflux Impairment via Blood-Brain Barrier: Role of Transport Proteins
por: Nasyrova, Regina F., et al.
Publicado: (2023)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)

Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
por: Shnayder, Natalia A., et al.
Publicado: (2022)

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
por: Vaiman, Elena E., et al.
Publicado: (2022)

Therapeutic and Toxic Effects of Valproic Acid Metabolites
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders
por: Dobrodeeva, Vera S., et al.
Publicado: (2022)

Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis
por: Goncharova, Polina S., et al.
Publicado: (2021)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Clinical Experience of High Frequency and Low Frequency TENS in Treatment of Diabetic Neuropathic Pain in Russia
por: Al-Zamil, Mustafa, et al.
Publicado: (2022)

Valproate-Induced Metabolic Syndrome
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Association of Single-Nucleotide Polymorphisms Rs2779249 (chr17:26128581 C>A) and Rs rs2297518 (chr17: chr17:27769571 G>A) of the NOS2 Gene with Tension-Type Headache and Arterial Hypertension Overlap Syndrome in Eastern Siberia
por: Alyabyeva, Polina V., et al.
Publicado: (2023)

Association of the ACTN3 Gene’s Single-Nucleotide Variant Rs1815739 (R577X) with Sports Qualification and Competitive Distance in Caucasian Athletes of the Southern Urals
por: Balberova, Olga V., et al.
Publicado: (2023)

Cytokine Imbalance as a Biomarker of Intervertebral Disk Degeneration
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Genetic Factors of Nitric Oxide’s System in Psychoneurologic Disorders
por: Nasyrova, Regina F., et al.
Publicado: (2020)

The Role of Single Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Development of the Phenotype of Migraine and Arterial Hypertension
por: Moskaleva, Polina V., et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis Mimic Syndrome in a 24-Year-Old Man with Chiari 1 Malformation and Syringomyelia: A Clinical Case
por: Al-Zamil, Mustafa, et al.
Publicado: (2023)

High-Tech Methods of Cytokine Imbalance Correction in Intervertebral Disc Degeneration
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Efficiency of Direct Transcutaneous Electroneurostimulation of the Median Nerve in the Regression of Residual Neurological Symptoms after Carpal Tunnel Decompression Surgery
por: Al-Zamil, Mustafa, et al.
Publicado: (2023)

The Role of Single-Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Leukocyte Telomere Length as a Molecular Biomarker of Coronary Heart Disease
por: Zimnitskaya, Olga V., et al.
Publicado: (2022)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

The “Angiogenic Switch” and Functional Resources in Cyclic Sports Athletes
por: Balberova, Olga V., et al.
Publicado: (2021)

The Role of Polymorphisms in Collagen-Encoding Genes in Intervertebral Disc Degeneration
por: Trefilova, Vera V., et al.
Publicado: (2021)

Candidate Genes of Regulation of Skeletal Muscle Energy Metabolism in Athletes
por: Balberova, Olga V., et al.
Publicado: (2021)

Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review
por: Yakovleva, Kristina D., et al.
Publicado: (2022)

Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity
por: Shnayder, Natalia A., et al.
Publicado: (2022)

Use of antipsychotics and long-term risk of parkinsonism
por: d’Errico, Angelo, et al.
Publicado: (2021)

Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management
por: Ward, Kristen M., et al.
Publicado: (2018)

The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia
por: Kamaeva, Daria A., et al.
Publicado: (2023)

Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications
por: Shleeva, Margarita O., et al.
Publicado: (2023)

Tau in the Pathophysiology of Parkinson’s Disease
por: Pan, Lina, et al.
Publicado: (2021)

Pathophysiology and Symptomatology of Drooling in Parkinson’s Disease
por: Polychronis, Sotirios, et al.
Publicado: (2022)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis
por: Jethwa, Ketan Dipak, et al.
Publicado: (2015)

Prospects for the Personalized Multimodal Therapy Approach to Pain Management via Action on NO and NOS
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_and7jam9tadpcgnoc89di52eu3